To confirm these results, normal PBMCs were transfected with shRNA targeting TLR3, TLR4, TLR8 and TLR9, and then stimulated with the NSCLC plasma collected before chemotherapy. This evidence concerns the gene TLR4 and non-small cell lung carcinoma.